[Blood circulation studies with 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].
D000818:Animals; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001775:Blood Circulation / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D004285:Dogs; D007093:Imidazoles / Q000009:adverse effects / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology
D000959:Antihypertensive Agents; D007093:Imidazoles; D013565:Sympatholytics; D001285:Atropine; D012110:Reserpine
Kreislaufuntersuchungen mit 2-(2,6-Dichlorphenylamino)-2-imidazolin-hydrochlorid.